The cancer risk associated with the heartburn drug ranitidine, a generic form of Zantac, led to voluntary recalls and FDA investigation. A California lab is also researching its potential dangers. Dr. Jon LaPook provides an exclusive look at the lab on "CBS This Morning.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing